Literature DB >> 12757710

Aging reduces proliferative capacities of liver by switching pathways of C/EBPalpha growth arrest.

Polina Iakova1, Samir S Awad, Nikolai A Timchenko.   

Abstract

The liver is capable of completely regenerating itself in response to injury and after partial hepatectomy. In liver of old animals, the proliferative response is dramatically reduced, the mechanism for which is unknown. The liver specific protein, C/EBPalpha, normally arrests proliferation of hepatocytes through inhibiting cyclin dependent kinases (cdks). We present evidence that aging switches the liver-specific pathway of C/EBPalpha growth arrest to repression of E2F transcription. We identified an age-specific C/EBPalpha-Rb-E2F4 complex that binds to E2F-dependent promoters and represses these genes. The C/EBPalpha-Rb-E2F4 complex occupies the c-myc promoter and blocks induction of c-myc in livers of old animals after partial hepatectomy. Our results show that the age-dependent switch from cdk inhibition to repression of E2F transcription causes a loss of proliferative response in the liver because of an inability to induce E2F target genes after partial hepatectomy providing a possible mechanism for the age-dependent loss of liver regenerative capacity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12757710     DOI: 10.1016/s0092-8674(03)00318-0

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  81 in total

1.  The reduction of SIRT1 in livers of old mice leads to impaired body homeostasis and to inhibition of liver proliferation.

Authors:  Jingling Jin; Polina Iakova; Yanjun Jiang; Estela E Medrano; Nikolai A Timchenko
Journal:  Hepatology       Date:  2011-07-27       Impact factor: 17.425

2.  Identification of age-specific Nrf2 binding to a novel antioxidant response element locus in the Gclc promoter: a compensatory means for the loss of glutathione synthetic capacity in the aging rat liver?

Authors:  Swapna V Shenvi; Eric Smith; Tory M Hagen
Journal:  Aging Cell       Date:  2012-02-01       Impact factor: 9.304

3.  Pregnancy restores the regenerative capacity of the aged liver via activation of an mTORC1-controlled hyperplasia/hypertrophy switch.

Authors:  Yuval Gielchinsky; Neri Laufer; Efi Weitman; Rinat Abramovitch; Zvi Granot; Yehudit Bergman; Eli Pikarsky
Journal:  Genes Dev       Date:  2010-03-15       Impact factor: 11.361

4.  E2f1-3 are critical for myeloid development.

Authors:  Prashant Trikha; Nidhi Sharma; Rene Opavsky; Andres Reyes; Clarissa Pena; Michael C Ostrowski; Martine F Roussel; Gustavo Leone
Journal:  J Biol Chem       Date:  2010-11-28       Impact factor: 5.157

5.  Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study.

Authors:  Jennifer C Lai; Jacqueline G O'Leary; James F Trotter; Elizabeth C Verna; Robert S Brown; R Todd Stravitz; Jeffrey D Duman; Lisa M Forman; Norah A Terrault
Journal:  Liver Transpl       Date:  2012-05       Impact factor: 5.799

6.  Repression of transcriptional activity of C/EBPalpha by E2F-dimerization partner complexes.

Authors:  Katrin Zaragoza; Valérie Bégay; Anja Schuetz; Udo Heinemann; Achim Leutz
Journal:  Mol Cell Biol       Date:  2010-02-22       Impact factor: 4.272

Review 7.  Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review.

Authors:  Y Yokoyama; M Nagino; Y Nimura
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

8.  Dominant-negative C/EBP disrupts mitotic clonal expansion and differentiation of 3T3-L1 preadipocytes.

Authors:  Jiang-Wen Zhang; Qi-Qun Tang; Charles Vinson; M Daniel Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-19       Impact factor: 11.205

9.  C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence.

Authors:  Thomas Sebastian; Radek Malik; Sara Thomas; Julien Sage; Peter Frederick Johnson
Journal:  EMBO J       Date:  2005-08-18       Impact factor: 11.598

10.  2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.